Haemonetics Corporation last reported quarterly results on Nov 5, 2026, for Q2 FY2027 (the quarter ended Sep 26, 2026): revenue of $357.8 million (+9.3% year over year) and diluted EPS of $1.00. It usually reports 40 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 4, 2027.
Results for Q3 FY2027, the quarter ending around Dec 26, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Feb 5, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 40 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 5, 2026
40 days after quarter end
|
Q2 FY2027
ended Sep 26, 2026
|
358
+9.3%
|
46
+19.7%
|
1.00
+23.5%
|
|
Aug 6, 2026
40 days after quarter end
|
Q1 FY2027
ended Jun 27, 2026
|
339
+5.6%
|
33
-3.0%
|
0.72
+2.9%
|
|
May 7, 2026
40 days after quarter end
|
Q4 FY2026
ended Mar 28, 2026
|
346
+4.8%
|
-20
-134.7%
|
-0.43
-137.0%
|
|
Feb 5, 2026
40 days after quarter end
|
Q3 FY2026
ended Dec 27, 2025
|
339
-2.7%
|
45
+19.3%
|
0.95
+28.4%
|
|
Nov 6, 2025
40 days after quarter end
|
Q2 FY2026
ended Sep 27, 2025
|
327
-5.3%
|
39
+14.3%
|
0.81
+22.7%
|
|
Aug 7, 2025
40 days after quarter end
|
Q1 FY2026
ended Jun 28, 2025
|
321
-4.4%
|
34
-11.3%
|
0.70
-5.4%
|
|
May 8, 2025
40 days after quarter end
|
Q4 FY2025
ended Mar 29, 2025
|
331
-3.7%
|
58
+184.7%
|
1.17
+195.8%
|
|
Feb 6, 2025
40 days after quarter end
|
Q3 FY2025
ended Dec 28, 2024
|
349
+3.7%
|
37
+20.0%
|
0.74
+21.3%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- HAE (NYSE)
- Fiscal year ends
- April 3
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 313143
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.